Greenfield Global receives EXCiPACT GMP certification
Greenfield certification set to boost client manufacturing capabilities
BROOKFIELD — Greenfield Global Inc., a Canadian ethanol producer and a global leader in the production of high-purity specialty alcohols and solvents, announced on Dec. 8 that it had been awarded the Excipient Quality System (EXCiPACT) Good Manufacturing Practice (GMP) certification for specific ethanol, acetone, and IPA products at its Brookfield, Connecticut site.
EXCiPACT, an independent, globally recognized certification, is the industry-accepted guideline for managing supply chain risks related to excipients, which are inactive substances that serve as a vehicle for medicinal drugs or other active substances. The rigorous assessment process and subsequent EXCiPACT certification demonstrate that Greenfield Global manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.
“This certification reflects Greenfield Global’s commitment to providing high-quality products and services to our customers,” said Frank Richards, EVP & Managing Director, Specialty Chemicals and Ingredients. “For over 30 years, Greenfield Global under its Pharmco brand has ensured that its product safety standards meet or exceed regulatory and customer requirements.”
“This certification confirms our commitment to GMP in the manufacturing and supply of our products, as well as the safe, reliable, and transparent pharmaceutical supply chain we use to deliver them to our customers quickly and dependably.” Richards added.
Greenfield Global’s newly opened Portlaoise, Ireland facility will be targeting EXCiPACT certification, likely to be achieved in 2021.